8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
Iovance Biotherapeutics, Inc.（CIK 0001425205）于 2026-10-29 向 SEC 提交 8-K 文件，报告日期为 2026-10-29，文件包含 Item 8.01（其他事件）和 Item 9.01（财务报表与附件），共 13 份文件。文件未在素材中披露其他事件的具体内容。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-29
Accepted
2026-10-29 17:00:28
Documents
13
Period of Report
2026-10-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)
EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 261502701
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov